Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis.

Tatjana SchwarzCarolin OttoTerry C JonesFlorence PachePatrick SchindlerMoritz NiederschweibererFelix A SchmidtChristian DrostenVictor Max CormanKlemens Ruprecht

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)

These findings should inform treatment decisions and SARS-CoV-2 vaccination management in pwMS.

Keyphrases

sars cov
multiple sclerosis
respiratory syndrome coronavirus
coronavirus disease
smoking cessation